Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods for inhibiting diabetic retinopathy with an antibody against integrin associated protein (IAP)

Methods for inhibiting diabetic retinopathy with an antibody against integrin associated protein (IAP)

US Patent 8613922 · Granted Dec 24, 2013

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Heparin-binding domain of IGFBP-2 in the treatment of metabolic disorders2021
Compounds, compositions and uses thereof for improvement of bone disorders2021
Monoclonal antibodies for enhancing or inhibiting insulin-like growth factor-I2018
Monoclonal antibodies for enhancing or inhibiting insulin-like growth factor-I2018
Monoclonal antibodies for enhancing or inhibiting insulin-like growth factor 1 (2017
Monoclonal antibodies for enhancing or inhibiting insulin-like growth factor 1 (2017
Antagonists of IAP-SHPS1 interaction2016
Antagonists of IAP-SHPS1 interaction2016
Compounds and methods for treating bone disorders and controlling weight2015
Monoclonal antibodies for enhancing or inhibiting insulin-like growth factor 1 (2015
Monoclonal antibodies for enhancing or inhibiting insulin-like growth factor 1 (2015
Monoclonal antibodies for enhancing or inhibiting insulin-like growth factor-I2015